Each tablet contains Cefixime 100 mg / 200 mg.

Ritecef O Tablets contain Cefixime, a third-generation oral cephalosporin antibiotic with broad-spectrum bactericidal activity against Gram-positive and Gram-negative bacteria. It is effective in the treatment of urinary tract infections, respiratory tract infections, and biliary tract infections caused by susceptible organisms. Its excellent stability against many β-lactamases enhances its efficacy against resistant bacterial strains, making it a reliable option for managing a wide range of bacterial infections.

Ritecef O Tablets are indicated for the treatment of urinary tract infections (UTIs), respiratory tract infections, and biliary tract infections caused by susceptible bacterial pathogens.

Cefixime is a semi-synthetic, oral third-generation cephalosporin with potent bactericidal activity against a broad spectrum of Gram-positive and Gram-negative organisms. It exerts its antibacterial effect by inhibiting bacterial cell wall synthesis, leading to bacterial cell lysis and death. Cefixime demonstrates excellent stability against many β-lactamase enzymes, making it effective against numerous resistant bacterial strains.

The recommended adult dosage is 400 mg per day, which may be administered as 200 mg every 12 hours, or as directed by the treating physician.

Ritecef O Tablets are contraindicated in patients with known hypersensitivity to Cefixime, other cephalosporins, or any component of the formulation.